CEO, President of Bruker Corp (30-Year Financial, Insider Trades) Frank H Laukien (insider trades) bought 2,500 shares of BRKR on 05/11/2020 at an average price of $39.11 a share. The total cost of this purchase was $97,775.
Bruker Corp is a developer, manufacturer and distributor of scientific instruments and analytical and dignostic solutions that enable customers to explore life and materials at microscopic, molecular and cellular levels. Bruker Corp has a market cap of $5.78 billion; its shares were traded at around $37.50 with a P/E ratio of 33.17 and P/S ratio of 2.87. The dividend yield of Bruker Corp stocks is 0.42%. Bruker Corp had annual average EBITDA growth of 7.50% over the past ten years. GuruFocus rated Bruker Corp the business predictability rank of 2.5-star. GuruFocus has detected 1 severe warning sign with Bruker Corp. .
CEO Recent Trades:
- CEO, President, 10% Owner Frank H Laukien bought 2,500 shares of BRKR stock on 05/11/2020 at the average price of $39.11. The price of the stock has decreased by 4.12% since.
Directors and Officers Recent Trades:
- Director Cynthia M Friend sold 1,000 shares of BRKR stock on 05/11/2020 at the average price of $39.06. The price of the stock has decreased by 3.99% since.
- Director Gilles Gerard Jean Martin sold 30,000 shares of BRKR stock on 05/11/2020 at the average price of $38.83. The price of the stock has decreased by 3.43% since.
For the complete insider trading history of BRKR, click here
.
